½ÃÀ庸°í¼­
»óǰÄÚµå
1760698

¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå º¸°í¼­(2025³â)

Prebiotics For Infant Formula Global Market Report 2025

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̸ç 2029³â±îÁö 8.1%ÀÇ CAGR·Î 23¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ¹Ì»ý¹° ±â¹Ý ¿µ¾ç¿¡ ´ëÇÑ °ü½É Áõ°¡, ¸ÂÃãÇü Á¶Á¦ºÐÀ¯¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀþÀº ºÎ¸ðµéÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡, ÇÁ¸®¹Ì¾ö ÀÌÀ¯½Ä ºê·£µåÀÇ Á¸Àç°¨ È®´ë, Àå±âÀûÀÎ °Ç°­ È¿°ú¸¦ À§ÇÑ Á¶±â ¿µ¾ç¿¡ ´ëÇÑ °­Á¶ °­È­ µî¿¡ ±âÀÎÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¼ººÐ ¹èÇÕ ±â¼ú ¹ßÀü, ½Å¹ÙÀÌ¿Àƽ½º Á¦Ç° °³¹ß Çõ½Å, Àå °Ç°­ R&D ÅõÀÚ Áõ°¡, À¯¾Æ¿ë Á¶Á¦ºÐÀ¯ »ý»êÀÇ ¹ßÀü, Áö¿ªº° ÇÁ¸®¹ÙÀÌ¿Àƽ½º ºí·»µå °³¹ß µîÀÌ ÀÖ½À´Ï´Ù.

À¯±â³ó Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÇâÈÄ ¼ö³â°£ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯±â³ó Á¦Ç°Àº ÇÕ¼ºÈ­ÇÐÁ¦Ç°, ºñ·á, À¯ÀüÀÚ º¯ÇüÀÛ¹°(GMO)À» »ç¿ëÇÏÁö ¾Ê°í Àç¹è ¶Ç´Â »ý»êµÈ Á¦Ç°ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼±È£µµ Áõ°¡´Â ¼ÒºñÀÚµéÀÌ ÇÕ¼º ¹°Áú°ú °ü·ÃµÈ °Ç°­ À§Çè¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁø °ÍÀÌ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿¡ ÇÔÀ¯µÈ ÇÁ¸®¹ÙÀÌ¿Àƽ½º´Â õ¿¬ Àå °Ç°­À» ÃËÁøÇϰí À¯¾ÆÀÇ ¸é¿ª ü°è ¹ß´ÞÀ» Áö¿øÇÔÀ¸·Î½á À¯±â³ó Á¦Ç°À» º¸¿ÏÇÕ´Ï´Ù. ¸ðÀ¯ÀÇ ±àÁ¤ÀûÀÎ È¿°ú¸¦ ÀçÇöÇϰí, ±ÕÇü ÀâÈù ¹Ì»ý¹°ÀÇ ±ÕÇüÀ» À¯ÁöÇϸç, Ŭ¸° ¶óº§ ¿îµ¿¿¡ ºÎÇÕÇϱ⠶§¹®¿¡ °Ç°­ ÁöÇâÀûÀ̰í ȯ°æ ģȭÀûÀÎ °¡Á¤¿¡ ÀûÇÕÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 5¿ù ¾Æ¸£ÇîÆ¼³ª¿¡ º»»ç¸¦ µÐ À¯±â³ó Á¦Ç° ÀÎÁõ ±â°üÀÎ LETIS S.A.´Â 2022³â À¯±â³ó ½Äǰ ¸ÅÃâÀÌ 616¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇØ 2021³â ´ëºñ 4.3% Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌó·³ À¯±â³ó Á¦Ç°À¸·ÎÀÇ ÀüȯÀÌ Áõ°¡Çϸ鼭 À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº Àå °Ç°­À» Áö¿øÇϰí À¯¾ÆÀÇ ¸é¿ª ±â´ÉÀ» Çâ»ó½ÃŰ´Â Çõ½ÅÀûÀÎ ¹ÙÀÌ¿Àƽ½º Á¦Á¦ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿Àƽ½º Á¦Á¦´Â ÇÁ·Î¹ÙÀÌ¿Àƽ½º, ÇÁ¸®¹ÙÀÌ¿Àƽ½º, Æ÷½ºÆ®¹ÙÀÌ¿Àƽ½º, ½Å¹ÙÀÌ¿Àƽ½º µî ´Ù¾çÇÑ ½ÄÀ̺¸ÃæÁ¦¸¦ Æ÷ÇÔÇϸç, Àå °Ç°­ ÁõÁø, ¸é¿ª ü°è °­È­, Àü¹ÝÀûÀÎ °Ç°­ ÁõÁøÀ» À§ÇØ °í¾ÈµÈ Á¦Ç°ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹¿¡ º»»ç¸¦ µÐ À½·á ¹× ½Äǰ ȸ»çÀÎ ÇØÇÇ ÆÐ¹Ð¸® ¿À°¡´Ð½º(Happy Family Organics)´Â 2024³â 9¿ù USDA(¹Ì±¹ ³ó¹«ºÎ) ÀÎÁõ À¯±â³ó À¯¾Æ¿ë Á¶Á¦ºÐÀ¯ Á¦Ç°ÀÎ ÇØÇÇ ÆÐ¹Ð¸® ¿À°¡´Ð½º ¹ÙÀÌ¿Àƽ½º(Happy Family Organics Infant Formula)¸¦ Ãâ½ÃÇß½À´Ï´Ù. USDA(¹Ì±¹ ³ó¹«ºÎ) ÀÎÁõÀ» ¹ÞÀº »õ·Î¿î À¯±â³ó À¯¾Æ¿ë Á¶Á¦ºÐÀ¯ ½Ã¸®Áî·Î, ÇÁ·Î¹ÙÀÌ¿Àƽ½º¿Í ÇÁ¸®¹ÙÀÌ¿Àƽ½º¸¦ ¸ðµÎ ÅëÇÕÇÏ¿© À¯¾ÆÀÇ ¼ÒÈ­±â ¹× ¸é¿ª ü°è °Ç°­À» Áö¿øÇÕ´Ï´Ù. ÀÌ Æ÷¹Ä·¯´Â Àå³» ¼¼±ÕÃÑ ¹ß´Þ¿¡ Áß¿äÇÑ ½Ã±âÀÎ »ýÈÄ 1,000ÀÏ µ¿¾È ¿µ¾Æ¿¡°Ô ¿µ¾çÀ» °ø±ÞÇÒ ¼ö ÀÖµµ·Ï Á¶Á¤µÇ¾ú½À´Ï´Ù. ÇÁ¸®¹ÙÀÌ¿Àƽ½º°¡ ÇÔÀ¯µÇ¾î ÀÖ¾î À¯ÀÍÇÑ Àå³» ¹ÚÅ׸®¾ÆÀÇ Áõ½ÄÀ» ÃËÁøÇÏ°í ¸é¿ª·Â°ú Àü¹ÝÀûÀÎ °Ç°­À» ´õ¿í Áö¿øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º PESTEL ºÐ¼®(Á¤Ä¡, »çȸ, ±â¼ú, ȯ°æ, ¹ýÀû ¿äÀÎ, ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ)
  • ÃÖÁ¾ ÀÌ¿ë »ê¾÷ ºÐ¼®
  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå : ¼ºÀå·ü ºÐ¼®
  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå ½ÇÀû : ±Ô¸ð¿Í ¼ºÀå, 2019-2024
  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå ¿¹Ãø : ±Ô¸ð¿Í ¼ºÀå, 2024-2029, 2034F
  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º Àüü ½ÃÀå(TAM)

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå : ÇÁ¸®¹ÙÀÌ¿Àƽ½º À¯Çüº°, ½ÇÀû°ú ¿¹Ãø, 2019-2024, 2024-2029F, 2034F
  • ÇÁ¶ôÅä¿Ã¸®°í´ç(FOS)
  • °¥¶ôÅä¿Ã¸®°í´ç(GOS)
  • ÀÌ´­¸°
  • ´Ü¼â ÇÁ¶ôÅä¿Ã¸®°í´ç(scFOS)
  • ¿ÏÃæ ¿Ã¸®°í´ç
  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå : ±â´Éº°, ½ÇÀû°ú ¿¹Ãø, 2019-2024, 2024-2029F, 2034F
  • ¼ÒÈ­±â°è °Ç°­ °³¼±
  • ¸é¿ª ¹ÝÀÀ °­È­
  • ¹Ì³×¶ö Èí¼ö ÃËÁø
  • Àå³» ¼¼±Õ Áõ½Ä ÃËÁø
  • À§ÀåÀå¾Ö °æ°¨
  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå : ¿ëµµº°, ½ÇÀû°ú ¿¹Ãø, 2019-2024, 2024-2029F, 2034F
  • Ç¥ÁØ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯
  • ÆÈ·Î¾÷ Æ÷¹Ä·¯
  • ½ºÆä¼ÈƼ Æ÷¹Ä·¯
  • ±âŸ ¿ëµµ
  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ½ÇÀû°ú ¿¹Ãø, 2019-2024, 2024-2029F, 2034F
  • ¿Â¶óÀÎ ¸¶ÄÏÇ÷¹À̽º
  • À¯¾Æ¿ë Á¶Á¦ºÐÀ¯ Á¦Á¶¾÷ü
  • ÇコÄɾî Á¾»çÀÚ
  • ¼Ò¸Å¾÷ü¿Í ÆÇ¸Å¾÷ü
  • ºÎ¸ð¿Í º¸È£ÀÚ
  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå, ÇÁ¶ôÅä¿Ã¸®°í´ç, À¯Çüº° ÇÏÀ§ ¼¼ºÐÈ­ : ½ÇÀû°ú ¿¹Ãø, 2019-2024, 2024-2029F, 2034F
  • ¼±Çü ÇÁ¶ôÅä¿Ã¸®°í´ç
  • ºÐ±âÇü ÇÁ¶ôÅä¿Ã¸®°í´ç
  • °í¼øµµ ÇÁ¶ôÅä¿Ã¸®°í´ç
  • È¿¼Ò ÇÕ¼º ÇÁ¶ôÅä¿Ã¸®°í´ç
  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå, °¥¶ôÅä¿Ã¸®°í´ç, À¯Çüº° ÇÏÀ§ ¼¼ºÐÈ­ : ½ÇÀû°ú ¿¹Ãø, 2019-2024, 2024-2029F, 2034F
  • °í °¥¶ôÅä¿Ã¸®°í´ç ÇÔÀ¯·®
  • Àú °¥¶ôÅä¿Ã¸®°í´ç ÇÔÀ¯·®
  • ¥â-°¥¶ôÅä¿Ã¸®°í´ç
  • ¥á-°¥¶ôÅä¿Ã¸®°í´ç
  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå, ÀÌ´­¸°, À¯Çüº° ÇÏÀ§ ¼¼ºÐÈ­ : ½ÇÀû°ú ¿¹Ãø, 2019-2024, 2024-2029F, 2034F
  • ´Ü¼â ÀÌ´­¸°
  • Àå¼â ÀÌ´­¸°
  • õ¿¬ ÀÌ´­¸°
  • ¿Ã¸®°íÇÁ¶ôÅä¿À½º °­È­ ÀÌ´­¸°
  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå, ´Ü¼â ÇÁ¶ôÅä¿Ã¸®°í´ç, À¯Çüº° ÇÏÀ§ ¼¼ºÐÈ­ : ½ÇÀû°ú ¿¹Ãø, 2019-2024, 2024-2029F, 2034F
  • ±Û·çÄÚ½º ±â¹Ý ´Ü¼â ÇÁ¶ôÅä¿Ã¸®°í´ç
  • ÀÚ´ç ±â¹Ý ´Ü¼â ÇÁ¶ôÅä¿Ã¸®°í´ç
  • ½Ä¹° À¯·¡ ´Ü¼â ÇÁ¶ôÅä¿Ã¸®°í´ç
  • »ó¾÷ µî±Þ¿ë ´Ü¼â ÇÁ¶ôÅä¿Ã¸®°í´ç
  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå, ¿ÏÃæ ¿Ã¸®°í´ç, À¯Çüº° ÇÏÀ§ ¼¼ºÐÈ­ : ½ÇÀû°ú ¿¹Ãø, 2019-2024, 2024-2029F, 2034F
  • pH ¾ÈÁ¤È­ ¿ÏÃæ ¿Ã¸®°í´ç
  • ¹Ì³×¶ö °­È­ ¿ÏÃæ ¿Ã¸®°í´ç
  • À¯±â»ê ¿ÏÃæ ¿Ã¸®°í´ç
  • ¸ÖƼ ¿ÏÃæ ¿Ã¸®°í´ç ºí·»µå

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå : Áö¿ªº°, ½ÇÀû°ú ¿¹Ãø, 2019-2024, 2024-2029F, 2034F
  • ¼¼°èÀÇ À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå : ±¹°¡º°, ½ÇÀû°ú ¿¹Ãø, 2019-2024, 2024-2029F, 2034F

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

  • À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå : °æÀï ±¸µµ
  • À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå : ±â¾÷ °³¿ä
    • Nestle S.A. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danone S.A. Overview, Products and Services, Strategy and Financial Analysis
    • FrieslandCampina Overview, Products and Services, Strategy and Financial Analysis
    • Ingredion Incorporated Overview, Products and Services, Strategy and Financial Analysis

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

  • Morinaga Milk Industry Co. Ltd.
  • Yakult Honsha Co. Ltd.
  • Tate & Lyle PLC
  • HiPP GmbH & Co. Vertrieb KG
  • Glanbia Nutritionals
  • ByHeart Inc.
  • Synutra International Inc.
  • BUBS Australia Ltd.
  • Dana Dairy Group
  • Bobbie Baby Inc
  • New Francisco(Yunfu City) Biotechnology Corporation
  • Glycosyn Inc.
  • Clasado Biosciences Limited
  • zuChem Inc.
  • Dupont Nutrition & Health

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

  • À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå 2029 : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ±¹°¡
  • À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå 2029 : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ºÎ¹®
  • À¯¾Æ¿ë Á¶Á¦ºÐÀ¯¿ë ÇÁ¸®¹ÙÀÌ¿Àƽ½º ½ÃÀå 2029 : ¼ºÀå Àü·«
    • ½ÃÀå µ¿Çâ¿¡ ±â¹ÝÇÑ Àü·«
    • °æÀï Àü·«

Á¦36Àå ºÎ·Ï

ksm 25.07.09

Prebiotics in infant formula are non-digestible components, often derived from dietary fibers such as galactooligosaccharides (GOS) and fructooligosaccharides (FOS), that help promote the growth of beneficial gut bacteria. These compounds replicate the role of human milk oligosaccharides (HMOs) found in breast milk, aiding in the development of a healthy gut microbiota, boosting immune function, and potentially lowering the risk of infections and allergies in infants.

The primary types of prebiotics used in infant formula include fructooligosaccharides (FOS), galactooligosaccharides (GOS), inulin, short-chain fructooligosaccharides (scFOS), and buffered oligosaccharides. Fructooligosaccharides (FOS) are plant-based prebiotics that support gut health by encouraging the growth of beneficial bacteria, enhancing digestion, and improving nutrient absorption. The benefits of prebiotics include better digestive health, strengthened immune responses, improved mineral absorption, support for beneficial gut bacteria growth, and a reduction in gastrointestinal disorders. These prebiotics are used in a range of products, including standard infant formula, follow-on formula, specialty formulas, and other related applications. The key end users are online marketplaces, infant formula manufacturers, healthcare professionals, retailers, distributors, as well as parents and caregivers.

The prebiotics for infant formula market research report is one of a series of new reports from The Business Research Company that provides prebiotics for infant formula market statistics, including the prebiotics for infant formula industry global market size, regional shares, competitors with the prebiotics for infant formula market share, detailed prebiotics for infant formula market segments, market trends, and opportunities, and any further data you may need to thrive in the prebiotics for infant formula industry. This prebiotics for infant formula market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The prebiotics for infant formula market size has grown strongly in recent years. It will grow from $1.59 billion in 2024 to $1.71 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth during the historical period can be credited to heightened awareness of infant gut health, a rising demand for organic baby food, an increasing incidence of gastrointestinal issues among infants, greater incorporation of prebiotics in pediatric nutrition, and higher birth rates in developing nations.

The prebiotics for infant formula market size is expected to see strong growth in the next few years. It will grow to $2.34 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to a rising interest in microbiome-based nutrition, increasing demand for personalized infant formulas, higher healthcare spending by young parents, expanding presence of premium baby food brands, and a stronger emphasis on early-life nutrition for long-term health benefits. Key trends during this period include technological progress in ingredient formulation, innovation in synbiotic product development, increased investment in gut health research and development, advancements in infant formula production, and the creation of region-specific prebiotic blends.

The increasing demand for organic products is anticipated to drive the expansion of the prebiotics for infant formula market in the coming years. Organic products are those cultivated or produced without synthetic chemicals, fertilizers, or genetically modified organisms (GMOs). This growing preference is largely fueled by consumers becoming more aware of the health risks linked to synthetic substances. Prebiotics in infant formula complement organic products by promoting natural gut health and supporting immune system development in infants. They replicate the positive effects of breast milk, fostering a balanced microbiome and aligning with the clean-label movement, making them suitable for health-focused and environmentally conscious families. For example, in May 2024, LETIS S.A., an Argentina-based certifying body for organic products, reported that organic food sales reached $61.67 billion in 2022, reflecting a 4.3% increase from 2021. Thus, the growing shift toward organic products is fueling the growth of the prebiotics for infant formula market.

Leading players in the prebiotics for infant formula market are concentrating on creating innovative biotics formulations to support gut health and boost immune function in infants. Biotics formulations encompass dietary supplements-such as probiotics, prebiotics, postbiotics, and synbiotics-designed to enhance gut health, strengthen the immune system, and promote overall wellness. For instance, in September 2024, Happy Family Organics, a US-based food and beverage company, introduced Happy Family Organics infant formula with biotics. This new line of USDA-certified organic infant formulas integrates both probiotics and prebiotics to support digestive and immune health in babies. These formulations are tailored to nourish infants during the critical first 1,000 days of life, a vital period for developing the gut microbiome. The inclusion of prebiotics is intended to encourage the growth of beneficial gut bacteria, further supporting immune health and general well-being.

In July 2023, Bobbie Baby Inc., a US-based infant formula manufacturer, acquired Nature's One for an undisclosed sum. This strategic move bolsters Bobbie's presence in the infant nutrition sector by acquiring Nature's One's advanced production facility in Ohio. The acquisition enhances manufacturing efficiency for organic, iron-enriched formulas to meet rising demand and improve supply chain robustness. Nature's One is a US-based pediatric nutrition company known for its focus on prebiotics in infant formula.

Major players in the prebiotics for infant formula market are Nestle S.A., Abbott Laboratories, Danone S.A., FrieslandCampina, Ingredion Incorporated, Morinaga Milk Industry Co. Ltd., Yakult Honsha Co. Ltd., Tate & Lyle PLC, HiPP GmbH & Co. Vertrieb KG, Glanbia Nutritionals, ByHeart Inc., Synutra International Inc., BUBS Australia Ltd., Dana Dairy Group, Bobbie Baby Inc, New Francisco (Yunfu City) Biotechnology Corporation, Glycosyn Inc., Clasado Biosciences Limited, zuChem Inc., Dupont Nutrition & Health.

North America was the largest region in the prebiotics for infant formula market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in prebiotics for infant formula report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the prebiotics for infant formula market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prebiotics for infant formula market consists of sales of infant formula additives, infant prebiotic supplements, prebiotic-enriched baby formula, aptamil gold, lactogen pro1, similac 360 total care, and enfamil neuropro. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prebiotics For Infant Formula Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prebiotics for infant formula market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prebiotics for infant formula ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prebiotics for infant formula market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type Of Prebiotics: Fructooligosaccharides (FOS); Galactooligosaccharides (GOS); Inulin; Short-chain Fructooligosaccharides (scFOS); Buffered Oligosaccharides
  • 2) By Functionality: Digestive Health Improvement; Enhanced Immune Response; Mineral Absorption Enhancement; Growth Promotion Of Beneficial Gut Bacteria; Reduction Of Gastrointestinal Disorders
  • 3) By Application: Standard Infant Formula; Follow-On Formula; Specialty Formula; Other Applications
  • 4) By End-User: Online Marketplaces; Infant Formula Manufacturers; Healthcare Professionals; Retailers And Distributors; Parents And Caregivers
  • Subsegments:
  • 1) By Fructooligosaccharides: Linear Fructooligosaccharides; Branched Fructooligosaccharides; High-Purity Fructooligosaccharides; Enzyme-Synthesized Fructooligosaccharides
  • 2) By Galactooligosaccharides: High Galactooligosaccharide Content; Low Galactooligosaccharide Content; Beta-Galactooligosaccharides; Alpha-Galactooligosaccharides
  • 3) By Inulin: Short-Chain Inulin; Long-Chain Inulin; Native Inulin; Oligofructose-Enriched Inulin
  • 4) By Short-Chain Fructooligosaccharides: Glucose-Based Short-Chain Fructooligosaccharides; Sucrose-Based Short-Chain Fructooligosaccharides; Vegetable-Derived Short-Chain Fructooligosaccharides; Commercial-Grade Short-Chain Fructooligosaccharides
  • 5) By Buffered Oligosaccharides: PH-Stabilized Buffered Oligosaccharides; Mineral-Enriched Buffered Oligosaccharides; Organic Acid Buffered Oligosaccharides; Multi-Buffered Oligosaccharide Blends
  • Companies Mentioned: Nestle S.A.; Abbott Laboratories; Danone S.A.; FrieslandCampina; Ingredion Incorporated
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prebiotics For Infant Formula Market Characteristics

3. Prebiotics For Infant Formula Market Trends And Strategies

4. Prebiotics For Infant Formula Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Prebiotics For Infant Formula Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Prebiotics For Infant Formula PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Prebiotics For Infant Formula Market Growth Rate Analysis
  • 5.4. Global Prebiotics For Infant Formula Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Prebiotics For Infant Formula Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Prebiotics For Infant Formula Total Addressable Market (TAM)

6. Prebiotics For Infant Formula Market Segmentation

  • 6.1. Global Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fructooligosaccharides (FOS)
  • Galactooligosaccharides (GOS)
  • Inulin
  • Short-chain Fructooligosaccharides (scFOS)
  • Buffered Oligosaccharides
  • 6.2. Global Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Digestive Health Improvement
  • Enhanced Immune Response
  • Mineral Absorption Enhancement
  • Growth Promotion Of Beneficial Gut Bacteria
  • Reduction Of Gastrointestinal Disorders
  • 6.3. Global Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Infant Formula
  • Follow-On Formula
  • Specialty Formula
  • Other Applications
  • 6.4. Global Prebiotics For Infant Formula Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Online Marketplaces
  • Infant Formula Manufacturers
  • Healthcare Professionals
  • Retailers And Distributors
  • Parents And Caregivers
  • 6.5. Global Prebiotics For Infant Formula Market, Sub-Segmentation Of Fructooligosaccharides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Linear Fructooligosaccharides
  • Branched Fructooligosaccharides
  • High-Purity Fructooligosaccharides
  • Enzyme-Synthesized Fructooligosaccharides
  • 6.6. Global Prebiotics For Infant Formula Market, Sub-Segmentation Of Galactooligosaccharides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High Galactooligosaccharide Content
  • Low Galactooligosaccharide Content
  • Beta-Galactooligosaccharides
  • Alpha-Galactooligosaccharides
  • 6.7. Global Prebiotics For Infant Formula Market, Sub-Segmentation Of Inulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Short-Chain Inulin
  • Long-Chain Inulin
  • Native Inulin
  • Oligofructose-Enriched Inulin
  • 6.8. Global Prebiotics For Infant Formula Market, Sub-Segmentation Of Short-Chain Fructooligosaccharides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glucose-Based Short-Chain Fructooligosaccharides
  • Sucrose-Based Short-Chain Fructooligosaccharides
  • Vegetable-Derived Short-Chain Fructooligosaccharides
  • Commercial-Grade Short-Chain Fructooligosaccharides
  • 6.9. Global Prebiotics For Infant Formula Market, Sub-Segmentation Of Buffered Oligosaccharides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PH-Stabilized Buffered Oligosaccharides
  • Mineral-Enriched Buffered Oligosaccharides
  • Organic Acid Buffered Oligosaccharides
  • Multi-Buffered Oligosaccharide Blends

7. Prebiotics For Infant Formula Market Regional And Country Analysis

  • 7.1. Global Prebiotics For Infant Formula Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Prebiotics For Infant Formula Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prebiotics For Infant Formula Market

  • 8.1. Asia-Pacific Prebiotics For Infant Formula Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prebiotics For Infant Formula Market

  • 9.1. China Prebiotics For Infant Formula Market Overview
  • 9.2. China Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prebiotics For Infant Formula Market

  • 10.1. India Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prebiotics For Infant Formula Market

  • 11.1. Japan Prebiotics For Infant Formula Market Overview
  • 11.2. Japan Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prebiotics For Infant Formula Market

  • 12.1. Australia Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prebiotics For Infant Formula Market

  • 13.1. Indonesia Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prebiotics For Infant Formula Market

  • 14.1. South Korea Prebiotics For Infant Formula Market Overview
  • 14.2. South Korea Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prebiotics For Infant Formula Market

  • 15.1. Western Europe Prebiotics For Infant Formula Market Overview
  • 15.2. Western Europe Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prebiotics For Infant Formula Market

  • 16.1. UK Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prebiotics For Infant Formula Market

  • 17.1. Germany Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prebiotics For Infant Formula Market

  • 18.1. France Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prebiotics For Infant Formula Market

  • 19.1. Italy Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prebiotics For Infant Formula Market

  • 20.1. Spain Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prebiotics For Infant Formula Market

  • 21.1. Eastern Europe Prebiotics For Infant Formula Market Overview
  • 21.2. Eastern Europe Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prebiotics For Infant Formula Market

  • 22.1. Russia Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prebiotics For Infant Formula Market

  • 23.1. North America Prebiotics For Infant Formula Market Overview
  • 23.2. North America Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prebiotics For Infant Formula Market

  • 24.1. USA Prebiotics For Infant Formula Market Overview
  • 24.2. USA Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prebiotics For Infant Formula Market

  • 25.1. Canada Prebiotics For Infant Formula Market Overview
  • 25.2. Canada Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prebiotics For Infant Formula Market

  • 26.1. South America Prebiotics For Infant Formula Market Overview
  • 26.2. South America Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prebiotics For Infant Formula Market

  • 27.1. Brazil Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prebiotics For Infant Formula Market

  • 28.1. Middle East Prebiotics For Infant Formula Market Overview
  • 28.2. Middle East Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prebiotics For Infant Formula Market

  • 29.1. Africa Prebiotics For Infant Formula Market Overview
  • 29.2. Africa Prebiotics For Infant Formula Market, Segmentation By Type Of Prebiotics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Prebiotics For Infant Formula Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Prebiotics For Infant Formula Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prebiotics For Infant Formula Market Competitive Landscape And Company Profiles

  • 30.1. Prebiotics For Infant Formula Market Competitive Landscape
  • 30.2. Prebiotics For Infant Formula Market Company Profiles
    • 30.2.1. Nestle S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danone S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. FrieslandCampina Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Ingredion Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Prebiotics For Infant Formula Market Other Major And Innovative Companies

  • 31.1. Morinaga Milk Industry Co. Ltd.
  • 31.2. Yakult Honsha Co. Ltd.
  • 31.3. Tate & Lyle PLC
  • 31.4. HiPP GmbH & Co. Vertrieb KG
  • 31.5. Glanbia Nutritionals
  • 31.6. ByHeart Inc.
  • 31.7. Synutra International Inc.
  • 31.8. BUBS Australia Ltd.
  • 31.9. Dana Dairy Group
  • 31.10. Bobbie Baby Inc
  • 31.11. New Francisco (Yunfu City) Biotechnology Corporation
  • 31.12. Glycosyn Inc.
  • 31.13. Clasado Biosciences Limited
  • 31.14. zuChem Inc.
  • 31.15. Dupont Nutrition & Health

32. Global Prebiotics For Infant Formula Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prebiotics For Infant Formula Market

34. Recent Developments In The Prebiotics For Infant Formula Market

35. Prebiotics For Infant Formula Market High Potential Countries, Segments and Strategies

  • 35.1 Prebiotics For Infant Formula Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Prebiotics For Infant Formula Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Prebiotics For Infant Formula Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦